Download your free guide now
|

Organ Donation: A Must?

19 July 2007Ben Troke, Associate Solicitor

 

Chief Medical Officer (CMO) Sir Liam Donaldson thrust the subject of organ donation into the headlines yesterday, arguing that organs should be routinely taken without explicit consent unless the deceased has explicitly chosen to opt out of being a donor.

 

As Ben Troke, health law expert at Browne Jacobson, points out, the shortage of organs is a problem which is not improving. There are currently 7,304 people on the UK transplant list, and sadly these patients are dying at a rate of more than one a day while they wait.

 

At the same time, as the British Medical Association points out, “every year… bodies are buried or cremated complete with organs that could have been used to save lives.”

 

Objection to donation is not the root of the problem: opinion polls have consistently shown that 70-90% of Britons are willing to donate organs after death. Yet only 23% of the population are signed up to the Organ Donor Register.

 

At the heart of the matter is the issue of consent. In the wake of the Alder Hey scandal, when children’s organs were taken without consent, the Human Tissue Act 2004 came into force in September last year, emphasising the importance of consent. The principle remained that there should be no donation without explicit consent.

 

The Act allows for a nominated representative to make donation decisions on a deceased’s behalf, and also introduced a statutory checklist of those in a "qualifying relationship" who can consent to organ donation if the deceased did not express a view.

 

The CMO has proposed a fundamental change in law, suggesting legislation to presume consent unless the deceased has opted out.

 

This may take the form of a “soft” opt out, in which the family’s view may be taken into account, or a “strong” opt out, where only the deceased's registration of their own objection through a central NHS database is sufficient.

 

Ben points out that the issue of presumed consent is likely to throw up a series of ethical dilemmas to be taken into consideration:

 

  • Can consent really be “presumed” – or is this in reality matter of donation without consent?

 

  • How informed are the public about the organ donation process they will be presumed to consent to?

 

  • The CMO’s proposal appears to prioritise the social interest in availability of donor organs over that of the individual to control what happens to their body after death. 

 

  • However, other interests may need to be taken into account, such as the individual needs of patients waiting for transplants, the deceased's family's wishes, and the efficient use of healthcare resources: kidney dialysis costs around £21,000pa, compared to a one-off £4,700 for a kidney transplant.

 

  • Presumed consent may be incompatible with certain cultural, moral or religious views.

 

  • Some may oppose outright any clinical intervention without explicit consent, and see the CMO’s proposals as a ‘thin end of the wedge’. 

 

The ethical debate will no doubt roll on, but in the meantime, it is clear that the Human Tissue Act 2004 leaves the underlying organ shortage problem unresolved.

 

Return to Headlines